HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvia Vanzulli Selected Research

Chemokine Receptors

3/2012Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silvia Vanzulli Research Topics

Disease

7Neoplasms (Cancer)
12/2023 - 05/2002
4Inflammation (Inflammations)
01/2022 - 09/2014
4Infections
01/2017 - 12/2013
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 01/2018
2Pneumonia (Pneumonitis)
01/2019 - 01/2017
2Hemolytic-Uremic Syndrome
12/2015 - 03/2012
2Thrombocytopenia (Thrombopenia)
03/2012 - 02/2002
1Triple Negative Breast Neoplasms
12/2023
1Hypersensitivity (Allergy)
01/2022
1Allergic Contact Dermatitis
01/2022
1Neoplasm Metastasis (Metastasis)
12/2021
1Photosensitivity Disorders (Photodermatitis)
12/2021
1Lung Injury
01/2019
1Brucellosis (Malta Fever)
01/2017
1Mycosis Fungoides
10/2016
1T-Cell Lymphoma (Lymphoma, T Cell)
10/2016
1Fibrosis (Cirrhosis)
01/2016
1Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
09/2014
1Acute Kidney Injury (Acute Renal Failure)
03/2012
1Hemolytic Anemia
03/2012
1Adenocarcinoma
11/2008
1Fibrosarcoma
05/2008
1Carcinoma (Carcinomatosis)
05/2002
1Breast Neoplasms (Breast Cancer)
05/2002
1Breast Ductal Carcinoma
05/2002
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2002
1Lymphoid Leukemia
01/2002

Drug/Important Bio-Agent (IBA)

21-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2021 - 11/2008
2Shiga Toxin (Shigella Toxin)IBA
12/2015 - 03/2012
2Hormones (Hormone)IBA
10/2002 - 05/2002
1Albuterol (Salbutamol)FDA LinkGeneric
12/2023
1Paclitaxel (Taxol)FDA LinkGeneric
12/2023
1Histamine (Histamine Dihydrochloride)FDA Link
01/2022
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
01/2022
1Histamine Receptors (Histamine Receptor)IBA
01/2022
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2022
1AnthraquinonesIBA
12/2021
1physcioneIBA
12/2021
1Cadherins (E-Cadherin)IBA
01/2020
1CateninsIBA
01/2020
1Ephrin-B1 (Ephrin B1)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2020
1Coloring Agents (Dyes)IBA
01/2020
1OvalbuminIBA
01/2019
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2019
1FlavonoidsIBA
01/2018
1Silybin (Lagosa)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2017
1AerosolsIBA
01/2017
1Phosphates (Orthophosphate)IBA
01/2017
1Formaldehyde (Formol)FDA Link
10/2016
1MF 13IBA
10/2016
1ParaffinIBA
10/2016
1MicroRNAs (MicroRNA)IBA
10/2016
1Virulence Factors (Pathogenicity Factors)IBA
01/2016
1Urea (Carbamide)FDA LinkGeneric
12/2015
1Leukotriene C4IBA
12/2015
1LeukotrienesIBA
12/2015
1Cysteine (L-Cysteine)FDA Link
12/2015
1AntigensIBA
09/2014
1Ophthalmic Solutions (Eye Drops)IBA
09/2014
1Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric
09/2014
1CollagenIBA
12/2013
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2013
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
12/2013
1Chemokine ReceptorsIBA
03/2012
1Oxygen (Dioxygen)IBA
11/2008
1Neoplasm Antigens (Tumor Antigens)IBA
05/2008
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2008
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2008
1Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
05/2002
1Estrogens (Estrogen)FDA Link
05/2002
1Clodronic Acid (Clodronate)IBA
02/2002
1Inosine Triphosphate (ITP)IBA
02/2002
1Liposomes (Liposome)IBA
02/2002
1Vincristine (Oncovin)FDA LinkGeneric
01/2002
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2002

Therapy/Procedure

1Intranasal Administration
01/2019
1Conservative Treatment
01/2018
1Drug Therapy (Chemotherapy)
01/2018
1Radiotherapy
01/2018
1Photochemotherapy (Photodynamic Therapy)
11/2008
1Therapeutics
05/2008
1Immunotherapy
05/2008
1Aftercare (After-Treatment)
05/2002
1Isogeneic Transplantation
05/2002